中国人兽共患病学报
中國人獸共患病學報
중국인수공환병학보
CHINESE JOURNAL OF ZOONOSES
2014年
8期
816-820
,共5页
肖光文%汪雪涛%乔亚峰%邹尚平%叶振东
肖光文%汪雪濤%喬亞峰%鄒尚平%葉振東
초광문%왕설도%교아봉%추상평%협진동
鲍曼不动杆菌%碳氢霉烯酶%改良Hodge试验%β内酰胺酶
鮑曼不動桿菌%碳氫黴烯酶%改良Hodge試驗%β內酰胺酶
포만불동간균%탄경매희매%개량Hodge시험%β내선알매
A cinetobacter baumannii%carbapenemase%modified Hodge test%Beta lactamase
目的:了解梅州地区临床分离的耐碳青霉烯类鲍曼不动杆菌的耐药性,探讨其耐药机制及分子流行病学特征。方法收集梅州地区5所医院2012年1~12月临床分离的非重复耐碳青霉烯类鲍曼不动杆菌210株,采用K-B法检测药敏性,改良Hodge试验筛选耐碳青霉烯表型,PCR扩增IM P、VIM、OXA-23、OXA-24、OXA-51和OXA-58型碳氢霉烯酶基因,并测序。应用ERIC-PCR分型及同源性分析。结果药敏结果显示,17种药物除多粘菌素B耐药率为0.48%外,其他药敏耐药率都高于60%;改良 Hodge试验阳性菌株163株(77.62%)。扩增结果显示Bla-OXA-51的检出率为最高为94.29%(198/210),Bla-OXA-23的检出率次之为78.57%(165/210),Bla-VIM的检出率为4.29%(9/210),Bla-IM P、Bla-OXA-24、Bla-OXA-58均未被检出。210株菌株分为7个ERIC基因型,其中A型97株,B型44株,H型25株,为主要的流行克隆株。结论梅州地区临床分离的耐碳青霉烯类鲍曼不动杆菌耐药十分严重;产OXA-51、OXA-23和VIM 型碳氢霉烯酶是本地区鲍曼不动杆菌对碳青霉烯类药物耐药的重要机制,且耐碳青霉烯类鲍曼不动杆菌存在克隆的流行。
目的:瞭解梅州地區臨床分離的耐碳青黴烯類鮑曼不動桿菌的耐藥性,探討其耐藥機製及分子流行病學特徵。方法收集梅州地區5所醫院2012年1~12月臨床分離的非重複耐碳青黴烯類鮑曼不動桿菌210株,採用K-B法檢測藥敏性,改良Hodge試驗篩選耐碳青黴烯錶型,PCR擴增IM P、VIM、OXA-23、OXA-24、OXA-51和OXA-58型碳氫黴烯酶基因,併測序。應用ERIC-PCR分型及同源性分析。結果藥敏結果顯示,17種藥物除多粘菌素B耐藥率為0.48%外,其他藥敏耐藥率都高于60%;改良 Hodge試驗暘性菌株163株(77.62%)。擴增結果顯示Bla-OXA-51的檢齣率為最高為94.29%(198/210),Bla-OXA-23的檢齣率次之為78.57%(165/210),Bla-VIM的檢齣率為4.29%(9/210),Bla-IM P、Bla-OXA-24、Bla-OXA-58均未被檢齣。210株菌株分為7箇ERIC基因型,其中A型97株,B型44株,H型25株,為主要的流行剋隆株。結論梅州地區臨床分離的耐碳青黴烯類鮑曼不動桿菌耐藥十分嚴重;產OXA-51、OXA-23和VIM 型碳氫黴烯酶是本地區鮑曼不動桿菌對碳青黴烯類藥物耐藥的重要機製,且耐碳青黴烯類鮑曼不動桿菌存在剋隆的流行。
목적:료해매주지구림상분리적내탄청매희류포만불동간균적내약성,탐토기내약궤제급분자류행병학특정。방법수집매주지구5소의원2012년1~12월림상분리적비중복내탄청매희류포만불동간균210주,채용K-B법검측약민성,개량Hodge시험사선내탄청매희표형,PCR확증IM P、VIM、OXA-23、OXA-24、OXA-51화OXA-58형탄경매희매기인,병측서。응용ERIC-PCR분형급동원성분석。결과약민결과현시,17충약물제다점균소B내약솔위0.48%외,기타약민내약솔도고우60%;개량 Hodge시험양성균주163주(77.62%)。확증결과현시Bla-OXA-51적검출솔위최고위94.29%(198/210),Bla-OXA-23적검출솔차지위78.57%(165/210),Bla-VIM적검출솔위4.29%(9/210),Bla-IM P、Bla-OXA-24、Bla-OXA-58균미피검출。210주균주분위7개ERIC기인형,기중A형97주,B형44주,H형25주,위주요적류행극륭주。결론매주지구림상분리적내탄청매희류포만불동간균내약십분엄중;산OXA-51、OXA-23화VIM 형탄경매희매시본지구포만불동간균대탄청매희류약물내약적중요궤제,차내탄청매희류포만불동간균존재극륭적류행。
In order to survey antibiotic resistance of clinical isolates carbapenem-resistant A cinetobacter baumannii in Meizhou and to investigate resistance mechanism and molecular epidemiological characteristics ,a total of 210 non-duplicated clinical isolates of carbapenem-resistant Acinetobacter baumannii from January 2012 to December 2012 were collected .The K-B disk diffusion method was applied for the drug-susceptibility test ,a modified Hodge test was used for the screening of carbapen-emase ,PCR was used to amplify carbapenemase genes (including IMP ,VIM ,OXA-23 ,OXA-24 ,OXA-51 and OXA-58) ,and the positive products were sequenced .Enterobacterial repetitive intergenic consensus PCR (ERIC-PCR) was used for DNA typing and test of homology .Our results on the percentage of strains resistant for antibiotics tested were higher than 60% except for polymyxin B was 0 .48% .There were 163 positive strains by the modified Hodge test ,accounting for 77 .62% .OXA-51 gene was identified in 198 strains (94 .29% ) ,OXA-23 in 165 strains (78 .57% ) ,and VIM in 9 strains (4 .29% ) ,OXA-24 ,OXA-58 and IMP gene was not identified by PCR amplification .Seven genomic types were included in the 210 carbapenem-resistant Acinetobacter baumannii .The major prevalence types were Type A (97 strains) ,Type B (44 strains) and Type H (25 strains) . In conclusion ,multiple drug resistance of clinically isolated carbapenem-resistant A cinetobacter baumannii is a serious problem in Meizhou .Production of OXA-51 ,OXA-23 and IMP carbapenemases is an important mechanism of resistance to carbapenem antibiotics ,and there is prevalence of the same clones in these carbapenem-resistant strains .